We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-4.24%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$4.4B
AUM Growth
-$1.33B
(-23%)
Cap. Flow
-$405M
Cap. Flow
% of AUM
-9.2%
Top 10 Holdings %
Top 10 Hldgs %
53.32%
Holding
82
New
7
Increased
5
Reduced
49
Closed
11
Top Buys
| 1 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
+$220M |
| 2 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$52.1M |
| 3 |
Entrada Therapeutics
TRDA
|
+$47.4M |
| 4 |
Centene
CNC
|
+$26.5M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$24.6M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$100M |
| 2 |
argenx
ARGX
|
+$63.6M |
| 3 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$63.3M |
| 4 |
SkinHealth Systems
SKIN
|
+$61.9M |
| 5 |
Celldex Therapeutics
CLDX
|
+$38.3M |
Sector Composition
| 1 | Healthcare | 94.86% |
| 2 | Consumer Staples | 2.79% |
| 3 | Industrials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$349M
| $758M | 17.24% |
12,957,222
| – | – |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $262M | 5.96% |
22,716,086
+1,916,783
| +9% | +$21.4M |
|
|
SNCE
3
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $247M | 5.62% |
+990,412
| New | +$220M |
|
|
4
argenx
ARGX
$54B
| $183M | 4.15% |
521,643
-208,939
| -29% | -$63.6M |
|
5
LivaNova
LIVN
$4.36B
| $180M | 4.09% |
2,057,178
-133,841
| -6% | -$11.2M |
|
6
Kymera Therapeutics
KYMR
$9.39B
| $164M | 3.74% |
2,587,730
-205,978
| -7% | -$12M |
|
7
ADC Therapeutics
ADCT
$163M
| $151M | 3.42% |
7,451,029
-78,300
| -1% | -$1.89M |
|
8
Beam Therapeutics
BEAM
$3.17B
| $150M | 3.42% |
1,885,850
-89,156
| -5% | -$7.63M |
|
9
Krystal Biotech
KRYS
$10.3B
| $127M | 2.9% |
1,820,898
-161,534
| -8% | -$9.4M |
|
|
10
SkinHealth Systems
SKIN
$117M
| $123M | 2.79% |
5,082,805
-2,400,901
| -32% | -$61.9M |
|
11
Replimune Group
REPL
$813M
| $105M | 2.38% |
3,866,512
-211,600
| -5% | -$6.33M |
|
12
Atara Biotherapeutics
ATRA
$77M
| $101M | 2.31% |
257,511
-1,140
| -0.4% | -$480K |
|
|
IGMS
13
DELISTED
IGM Biosciences
IGMS
| $97.8M | 2.22% |
3,334,355
-91,100
| -3% | -$4.53M |
|
14
Nurix Therapeutics
NRIX
$2.48B
| $85.6M | 1.95% |
2,958,284
-134,793
| -4% | -$4.09M |
|
|
15
Celldex Therapeutics
CLDX
$3.01B
| $83.7M | 1.9% |
2,165,586
-877,712
| -29% | -$38.3M |
|
16
Absci
ABSI
$1.65B
| $65.9M | 1.5% |
8,031,094
| – | – |
|
|
VERV
17
DELISTED
Verve Therapeutics
VERV
| $63M | 1.43% |
1,708,536
-160,494
| -9% | -$6.74M |
|
18
Regenxbio
RGNX
$634M
| $62M | 1.41% |
1,897,223
-110,778
| -6% | -$3.77M |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $61.3M | 1.39% |
8,258,345
| – | – |
|
20
Scholar Rock
SRRK
$6.48B
| $60.8M | 1.38% |
2,447,926
-102,279
| -4% | -$2.82M |
|
|
RPTX
21
DELISTED
Repare Therapeutics
RPTX
| $58.8M | 1.34% |
2,789,496
+221,800
| +9% | +$5.22M |
|
|
NVTA
22
DELISTED
Invitae Corporation
NVTA
| $58.1M | 1.32% |
3,805,403
-1,512,074
| -28% | -$32.7M |
|
|
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
| $57.5M | 1.31% |
371,839
-215,535
| -37% | -$36.1M |
|
24
Stoke Therapeutics
STOK
$1.86B
| $53.9M | 1.23% |
2,246,668
-135,290
| -6% | -$3.23M |
|
25
UnitedHealth
UNH
$380B
| $52.5M | 1.19% |
104,488
-16,222
| -13% | -$7.34M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO